UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NO. 001-36534 IRADIMED CORPORATION (Exact Name of Registrant As Specified In Its Charter) Delaware 73-1408526 (State or other jurisdiction of (I.R.S. Emplo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) Delaware 73-1408526 (State or other j ...

Start Time: 11:00 January 1, 0000 11:29 AM ET IRADIMED Corporation (NASDAQ:IRMD) Q3 2019 Earnings Conference Call October 30, 2019, 11:00 AM ET Company Participants Leslie McDonnell - President and CEO Chris Scott - CFO and Secretary Roger Susi - Chairman, CTO Brent Johnson - EVP of Worldwide Sales and Marketing Conference Call Participants Scott Henry - ROTH Capital Lisa Springer - Singular Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the IRADIMED Corporation Third Quarter ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the Quarterly Period Ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number 1025 Willa Springs Drive Winte ...

IRadimed Corp (NASDAQ:IRMD) Q2 2019 Earnings Conference Call July 30, 2019 11:00 AM ET Company Participants Roger Susi - Founder, Chairman, CEO & President Brent Johnson - EVP, Worldwide Sales & Marketing Christopher Scott - CFO & Secretary Conference Call Participants Operator Ladies and gentlemen, thank you for standing by. Welcome to IRadimed Corporation Second Quarter 2019 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, July 30, 201 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-36534 IRADIMED CORPORATION (Exact name of Registrant as specified in its charter) Delaware 73-1408526 (State or other juris ...

IRadimed Corp (NASDAQ:IRMD) Q1 2019 Earnings Conference Call April 30, 2019 11:00 AM ET Company Participants Roger Susi - Founder, Chairman, CEO & President Brent Johnson - EVP, Worldwide Sales & Marketing Christopher Scott - CFO & Secretary Conference Call Participants Stefanos Crist - CJS Securities Scott Henry - Roth Capital Partners Operator Ladies and gentlemen, thank you for standing by. Welcome to the IRADIMED Corporation First Quarter 2019 Financial Results Conference Call. [Operator Instructions]. ...

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Address of principal executive offices) (Zip Code) OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NO. 001-36534 IRADIMED CORPORATION (Exact Name of Registrant As Specified In Its Char ...

iRadimed Corp. (NASDAQ:IRMD) Q4 2018 Earnings Conference Call February 6, 2019 11:00 AM ET Call Participants Roger Susi - Chief Executive Officer Brent Johnson - EVP of Worldwide Sales and Marketing Chris Scott - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities Scott Henry - ROTH Capital Operator Ladies and gentlemen thank you for standing by. Welcome to the iRadimed Corporation Fourth Quarter 2018 Financial Results Conference Call. At this time, all participants are in a li ...